← Evidence map

TrialClinical rheumatology2018

Tocilizumab reduces complement C3 and C4 serum levels in rheumatoid arthritis patients.

Ciro Romano et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

20 papers cite it

2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 29362962